La popularidad de medicamentos agonistas de GLP-1, como Ozempic , ha revolucionado el tratamiento de la obesidad , que afecta a ms 890 millones de personas en el mundo , y el sobrepeso , con 2500 millones de adultos (18 aos o ms), segn los ltimos datos emitidos por la Organizacin Mundial de la Salud (OMS)
Understanding 104 Fever: What Is It in Celsius
New metrics such as reformulation velocity, nutrition-adjusted ESG, sustainability-linked packaging and carbon footprint reduction are emerging as signals of resilience
Yes, many patients experience significant weight loss with compounded sublingual semaglutide
North Texas has invested heavily in obesity treatment over the past several years, and the growing number of GLP-1 providers reflects that
Roughly 20 to 30% of users, particularly those with severe chronic degeneration, report minimal improvement